BIOMAT Database Logo BIOMAT Database Logo

Extra-renal hormonal status in end-stage uraemia. 1983

I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010530 Peritoneal Dialysis Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. Dialyses, Peritoneal,Dialysis, Peritoneal,Peritoneal Dialyses
D010908 Pituitary Hormones, Anterior Hormones secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Structurally, they include polypeptide, protein, and glycoprotein molecules. Adenohypophyseal Hormones,Anterior Pituitary Hormones,Hormones, Adenohypophyseal,Hormones, Anterior Pituitary
D005260 Female Females
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol

Related Publications

I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi
Calcitropic hormonal status in north Indian patients with end-stage renal disease.
January 1999, The National medical journal of India,
I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi
Options in uraemia therapy for diabetics with end-stage renal disease.
January 2004, Prilozi,
I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi
Amyloidosis in patients with end-stage renal failure: uraemia associated or dialysis related?
January 1995, Contributions to nephrology,
I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi
Cardiovascular abnormalities in end stage renal failure: the effect of anaemia or uraemia?
August 1994, Archives of disease in childhood,
I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi
Mineral status in children with end stage renal failure.
November 1986, The International journal of artificial organs,
I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi
Advanced glycation endproducts and dicarbonyls in end-stage renal disease: associations with uraemia and courses following renal replacement therapy.
October 2020, Clinical kidney journal,
I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi
Colestimide can be used as a phosphate binder to treat uraemia in end-stage renal disease patients.
June 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi
Nutritional status and survival in end-stage renal disease patients.
January 1998, Mineral and electrolyte metabolism,
I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi
Volaemic status and dyspepsia in end-stage renal disease patients.
August 2015, Nephrology (Carlton, Vic.),
I P Bhalla, and Yashpal, and V K Garg, and S Malhotra, and V C Ohri, and D S Rastogi
Functional status of patients with end-stage renal disease.
May 1987, Mayo Clinic proceedings,
Copied contents to your clipboard!